The report provides a detailed analysis essential for establishing an Idoxuridine production plant. It encompasses all critical aspects necessary for Idoxuridine production, including the cost of Idoxuridine production, Idoxuridine plant cost, Idoxuridine production costs, and the overall Idoxuridine production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating an Idoxuridine production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.
Idoxuridine is an antiviral medication primarily used in the treatment of viral infections affecting the eyes. It is primarily used as a drug for managing herpes simplex keratitis, which is a corneal (eye) infection caused by the herpes simplex virus. It is commonly formulated as an ophthalmic solution or ointment for direct application to the eye under medical supervision.
It is mainly applied as an eye ointment or eye drops in the localised treatment of ocular herpes infections. It also plays an important role in controlling ocular viral infections and preventing corneal scarring that may lead to vision impairment. Idoxuridine is also studied for potential applications against other viral infections, but its primary role remains in managing herpes-related eye conditions. It helps reduce symptoms and lowers the risk of complications such as scarring of the cornea.
The market for Idoxuridine is mainly led by its application as an antiviral agent in ophthalmology, which contributes to its demand in the medical and pharmaceutical industries. Its application as a medication in the treatment of herpes simplex infections affecting the eyes and skin significantly supports its demand in the medical and pharmaceutical industries. The increasing prevalence of viral eye infections, advancements in pharmaceutical production, and ongoing research to improve drug formulations largely contribute to its market demand. Its involvement as a valuable component in antiviral therapy, due to its effectiveness in inhibiting viral DNA synthesis and reducing the severity of infection, also boosts its demand in the medical and healthcare sectors.
Its ongoing use in pharmaceutical research to study antiviral mechanisms and develop improved topical formulations also contributes to its market expansion. The availability and cost of raw materials like iodine derivatives and nucleoside intermediates, along with regulatory compliance and quality certifications, are the major factors that greatly affect industrial Idoxuridine procurement. Efficient production systems, reliable supplier networks, and optimised logistics also play an important role in shaping the global market.
Raw Material for Idoxuridine Production
According to the Idoxuridine production plant project report, the major raw materials for Idoxuridine production includes Uracil Deoxyriboside.
Production Process of Idoxuridine
The extensive Idoxuridine production cost report consists of the following industrial production process:
- Production via Uracil Deoxyriboside: The industrial production of Idoxuridine begins with uracil deoxyriboside as the starting material, which is refluxed with a mixture of iodine, nitric acid (HNO3), and chloroform. During this reaction, the iodine in the presence of nitric acid introduces an iodine atom at the 5-position of the uracil ring, which converts uracil deoxyriboside into 5-iodo-2′-deoxyuridine (Idoxuridine). The reaction mixture is maintained under reflux until the substitution is complete, after which it is cooled and neutralised. Then, the product is separated, washed to remove residual acids and unreacted iodine, and purified through recrystallisation to obtain Idoxuridine as a pure crystalline solid. This single-step iodination process is straightforward, efficient, and suitable for large-scale production.
Idoxuridine is a synthetic antiviral compound belonging to the class of nucleoside analogues. It is slightly soluble in water, sparingly soluble in alcohol, and practically insoluble in nonpolar solvents such as chloroform or ether. The molecular formula of the compound is C9H11IN2O5, and its molecular mass is 354.1 g/mol. It appears as a white to off-white crystalline powder that is odourless and stable under normal storage conditions. The melting point of Idoxuridine ranges from 170 degree Celsius to 175 degree Celsius, at which point it may begin to decompose. The compound should be kept away from light and moisture, as prolonged exposure can lead to its gradual decomposition. It should be handled with care, as ingestion or inhalation of dust may cause irritation. Appropriate protective clothing and gloves are recommended when handling the substance in laboratory settings.